XLONPHP
Market cap1.55bUSD
Dec 24, Last price
92.50GBP
1D
1.26%
1Q
-8.78%
Jan 2017
-16.85%
Name
Primary Health Properties PLC
Chart & Performance
Profile
Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 169,800 10.19% | 154,100 5.84% | 145,600 4.75% | |||||||
Cost of revenue | 31,100 | 22,200 | 20,500 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 138,700 | 131,900 | 125,100 | |||||||
NOPBT Margin | 81.68% | 85.59% | 85.92% | |||||||
Operating Taxes | (1,200) | 600 | 1,500 | |||||||
Tax Rate | 0.45% | 1.20% | ||||||||
NOPAT | 139,900 | 131,300 | 123,600 | |||||||
Net income | 27,300 -51.51% | 56,300 -59.81% | 140,100 25.09% | |||||||
Dividends | (89,500) | (81,600) | (74,400) | |||||||
Dividend yield | 6.45% | 5.10% | 3.42% | |||||||
Proceeds from repurchase of equity | (100) | 160,100 | ||||||||
BB yield | 0.01% | -7.36% | ||||||||
Debt | ||||||||||
Debt current | 2,400 | 2,400 | 2,300 | |||||||
Long-term debt | 1,326,900 | 1,300,200 | 1,277,400 | |||||||
Deferred revenue | 30,400 | 29,200 | 28,300 | |||||||
Other long-term liabilities | (1,358,100) | (22,100) | (31,900) | |||||||
Net debt | 1,314,700 | 1,253,900 | 1,241,100 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 86,600 | 79,300 | 100,200 | |||||||
CAPEX | 146,400 | |||||||||
Cash from investing activities | (44,600) | (47,300) | (147,100) | |||||||
Cash from financing activities | (114,900) | (37,000) | (22,700) | |||||||
FCF | 92,300 | 124,700 | 2,706,000 | |||||||
Balance | ||||||||||
Cash | 13,700 | 29,100 | 33,400 | |||||||
Long term investments | 900 | 19,600 | 5,200 | |||||||
Excess cash | 6,110 | 40,995 | 31,320 | |||||||
Stockholders' equity | 950,300 | 1,002,800 | 1,025,000 | |||||||
Invested Capital | 2,756,090 | 2,750,505 | 2,742,580 | |||||||
ROIC | 5.08% | 4.78% | 4.69% | |||||||
ROCE | 5.01% | 4.72% | 4.50% | |||||||
EV | ||||||||||
Common stock shares outstanding | 1,336,500 | 1,443,700 | 1,435,800 | |||||||
Price | 1.04 -6.32% | 1.11 -26.82% | 1.51 -0.92% | |||||||
Market cap | 1,387,287 -13.27% | 1,599,620 -26.41% | 2,173,801 3.96% | |||||||
EV | 2,701,987 | 2,853,520 | 3,414,901 | |||||||
EBITDA | 139,600 | 131,900 | 125,100 | |||||||
EV/EBITDA | 19.36 | 21.63 | 27.30 | |||||||
Interest | 47,400 | 45,500 | 44,100 | |||||||
Interest/NOPBT | 34.17% | 34.50% | 35.25% |